» Articles » PMID: 32974532

Brefeldin A and Cytochalasin B Reduce Dengue Virus Replication in Cell Cultures but Do Not Protect Mice Against Viral Challenge

Overview
Specialty Microbiology
Date 2020 Sep 25
PMID 32974532
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dengue is an emerging arboviral disease caused by dengue virus (DENV). DENV belongs to the family and genus . No specific anti-DENV drugs are currently available.

Methods: We investigated the antiviral activity of Brefeldin A (BFA) and Cytochalasin B (CB) against this infection. The drugs BFA and CB were used in the treatment of dengue-2 virus (DENV-2) infections in Vero cell cultures and in protection from lethality by post-challenge administration in Swiss mice. Viral load was quantified by qRT-PCR and plaque assay in Vero cell cultures, post-infection, treated or not with the drugs. Post-challenge drug levels were evaluated by survival analysis.

Results: Our results indicate that doses of 5 µg ml of BFA and 10 µg ml of CB are not toxic to the cells and induce a statistically significant inhibition of DENV-2 replication in Vero cells when compared to control. No BFA- or CB-treated mice survived the challenge with DENV-2.

Conclusion: These data suggest that BFA and CB have an antiviral action against DENV-2 replication in Vero cell culture, but do not alter infected mice mortality.

Citing Articles

Impact of Tick-Borne Infection on Compact Human Brain Endothelial Barrier.

Schweitzer F, Letoha T, Osterhaus A, Prajeeth C Int J Mol Sci. 2025; 26(5).

PMID: 40076965 PMC: 11901142. DOI: 10.3390/ijms26052342.


Combination of the Focus-Forming Assay and Digital Automated Imaging Analysis for the Detection of Dengue and Zika Viral Loads in Cultures and Acute Disease.

Bolivar-Marin S, Bosch I, Narvaez C J Trop Med. 2022; 2022:2177183.

PMID: 35911823 PMC: 9325612. DOI: 10.1155/2022/2177183.


A retrospective study on the socio-demographic factors and clinical parameters of dengue disease and their effects on the clinical course and recovery of the patients in a tertiary care hospital of Bangladesh.

Prattay K, Sarkar M, Shafiullah A, Islam M, Raihan S, Sharmin N PLoS Negl Trop Dis. 2022; 16(4):e0010297.

PMID: 35377886 PMC: 8979461. DOI: 10.1371/journal.pntd.0010297.


Antibacterial and Anticancer Activity and Untargeted Secondary Metabolite Profiling of Crude Bacterial Endophyte Extracts from Baker Leaves.

Sebola T, Uche-Okereafor N, Mekuto L, Makatini M, Green E, Mavumengwana V Int J Microbiol. 2021; 2020:8839490.

PMID: 33488726 PMC: 7803143. DOI: 10.1155/2020/8839490.


A Systems Biology Workflow for Drug and Vaccine Repurposing: Identifying Small-Molecule BCG Mimics to Reduce or Prevent COVID-19 Mortality.

Hajjo R, Tropsha A Pharm Res. 2020; 37(11):212.

PMID: 33025261 PMC: 7537965. DOI: 10.1007/s11095-020-02930-9.


References
1.
Anwyl R, Narahashi T . Action of colchicine and cytochalasin B on the acetylcholine receptor. Br J Pharmacol. 1979; 65(3):483-8. PMC: 1668649. DOI: 10.1111/j.1476-5381.1979.tb07855.x. View

2.
Pelham H . Multiple targets for brefeldin A. Cell. 1991; 67(3):449-51. DOI: 10.1016/0092-8674(91)90517-3. View

3.
Rice C, Lenches E, Eddy S, Shin S, Sheets R, Strauss J . Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science. 1985; 229(4715):726-33. DOI: 10.1126/science.4023707. View

4.
Ghosh S, Ahrens W, Phatak S, Hwang S, Schrum L, Bonkovsky H . Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes. J Viral Hepat. 2011; 18(10):e568-77. DOI: 10.1111/j.1365-2893.2011.01487.x. View

5.
Austin W, Wind M, Brown K . Differences in the toxicity and teratogenicity of cytochalasins D and E in various mouse strains. Teratology. 1982; 25(1):11-8. DOI: 10.1002/tera.1420250103. View